fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Pain monitoring helps assess the effectiveness of opioid-sparing approaches during surgery

Written by | 17 Oct 2021

A new study has shown that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology (Medasense, Israel). The study showed that the NOL monitor… read more.

Spinal and general anesthesia associated with similar outcomes in hip-fracture surgery

Written by | 15 Oct 2021

For survival and functional recovery, spinal anesthesia for hip-fracture surgery is not superior to general anesthesia, researchers reported on Oct. 9 in the NEJM/New England Journal of Medicine…. read more.

After outpatient surgery, NSAIDs top codeine for pain control with less side-effects

Written by | 26 Jul 2021

When prescribed following outpatient surgery, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen provide better pain control with less side-effects than the opioid codeine. Researchers reported these findings on June… read more.

Consuming a diet with more fish fats, less vegetable oils can reduce migraine headaches, study finds

Written by | 26 Jul 2021

This study of 182 adults with frequent migraines expanded on the team’s previous work on the impact of linoleic acid and chronic pain. Linoleic acid is a polyunsaturated… read more.

Laughing gas relieves symptoms in people with treatment-resistant depression

Written by | 21 Jul 2021

Washington University School of Medicine A single, one-hour treatment that involves breathing in a mixture of oxygen and nitrous oxide — otherwise known as laughing gas — significantly… read more.

FDA approves Vanta, a recharge-free implantable neurostimulator for chronic pain – Medtronic

Written by | 16 Jun 2021

Medtronic plc announced it has received FDA approval for Vanta, a high performance recharge-free implantable neurostimulator (INS) with a device life that can be optimized up to 11… read more.

Heron Therapeutics announces FDA approval of Zynrelef for the management of postoperative pain for up to 72 hours

Written by | 21 May 2021

Heron Therapeutics, Inc. announced that the FDA has approved Zynrelef (bupivacaine and meloxicam) extended-release solution for use in adults for soft tissue or periarticular instillation to produce postsurgical… read more.

One in four children want better pain treatment

Written by | 17 Apr 2021

After an appendectomy, a quarter (24.8%) of all children wanted a stronger pain treatment in the first 24 hours after their operation. Among children who had a tonsillectomy,… read more.

Statin therapy not linked to muscle pain

Written by | 14 Apr 2021

Article written by Bruce Sylvester There is no measurable link between statin therapy and concurrent muscle pain, researchers reported on Feb. 24, 2021 in the BMJ/British Medical Journal.

Nausea drugs alleviate post-concussion headache pain

Written by | 13 Apr 2021

Article written by Bruce Sylvester. Treatment with two anti-nausea medications appears to alleviate headaches which took patients to the emergency room in the weeks after the initial injury…. read more.

Antidepressant therapy not significantly effective for back and osteoarthritis pain

Written by | 21 Jan 2021

Article written by Bruce Sylvester Antidepressants do not appear to provide significant back or osteoarthritis pain relief, even though they are widely prescribed for such purposes, researchers reported… read more.

Methotrexate effective for pain and inflammation in knee osteoarthritis

Written by | 5 Dec 2020

Article written by Bruce Sylvester Researchers report that methotrexate is an effective treatment for people with knee osteoarthritis (OA) who have pain and inflammation.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.